# Susan Manzi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/susan-manzi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,764 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 64 |
| i10-index | 150 |
| Last Known Institution | Allegheny Health Network |
| OpenAlex ID | https://openalex.org/A5110506527 |
| Works | 267 |

## Researcher papers

- [Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/derivation-and-validation-of-the-systemic-lupus-international-collaborating/)
- [Association of Systemic Lupus Erythematosus with <i>C8orf13–BLK</i> and <i>ITGAM–ITGAX</i>](https://scholariq.org/papers/association-of-systemic-lupus-erythematosus-with-i-c8orf13-blk-i-and-i-itgam/)
- [A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus](https://scholariq.org/papers/a-large-scale-replication-study-identifies-tnip1-prdm1-jazf1-uhrf1bp1-and-il10/)
- [The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial](https://scholariq.org/papers/the-effect-of-combined-estrogen-and-progesterone-hormone-replacement-therapy-on/)
- [The frequency and outcome of lupus nephritis: results from an international inception cohort study](https://scholariq.org/papers/the-frequency-and-outcome-of-lupus-nephritis-results-from-an-international/)
- [A short course of BG9588 (anti–CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis](https://scholariq.org/papers/a-short-course-of-bg9588-anti-cd40-ligand-antibody-improves-serologic-activity/)
- [Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort](https://scholariq.org/papers/factors-associated-with-damage-accrual-in-patients-with-systemic-lupus/)
- [Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials](https://scholariq.org/papers/effects-of-belimumab-a-b-lymphocyte-stimulator-specific-inhibitor-on-disease/)
- [Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: Estimates obtained using hospitalization data](https://scholariq.org/papers/prevalence-of-adult-systemic-lupus-erythematosus-in-california-and-pennsylvania/)
- [Cancer risk in systemic lupus: An updated international multi-centre cohort study](https://scholariq.org/papers/cancer-risk-in-systemic-lupus-an-updated-international-multi-centre-cohort-study/)
- [Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study](https://scholariq.org/papers/seizure-disorders-in-systemic-lupus-erythematosus-results-from-an-international/)
- [Lymphoma risk in systemic lupus: effects of disease activity versus treatment](https://scholariq.org/papers/lymphoma-risk-in-systemic-lupus-effects-of-disease-activity-versus-treatment/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Atherosclerosis and Cardiovascular Diseases](https://scholariq.org/topics/atherosclerosis-and-cardiovascular-diseases/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Researcher university

- [Allegheny Health Network](https://scholariq.org/institutions/allegheny-health-network/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.